Your browser is no longer supported. Please, upgrade your browser.
Settings
KBLM KBL Merger Corp. IV daily Stock Chart
KBLM [NASD]
KBL Merger Corp. IV
Index- P/E203.04 EPS (ttm)0.05 Insider Own21.86% Shs Outstand14.88M Perf Week0.53%
Market Cap154.06M Forward P/E- EPS next Y- Insider Trans- Shs Float2.69M Perf Month1.12%
Income- PEG- EPS next Q- Inst Own62.26% Short Float0.01% Perf Quarter2.83%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio0.01 Perf Half Y5.13%
Book/sh1.21 P/B8.56 EPS next Y- ROA- Target Price- Perf Year-
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range9.82 - 10.69 Perf YTD1.52%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-3.13% Beta-
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low5.45% ATR0.03
Employees1 Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)67.84 Volatility0.09% 0.11%
OptionableNo Debt/Eq- EPS Q/Q271.10% Profit Margin- Rel Volume0.00 Prev Close10.35
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume39.04K Price10.35
Recom- SMA200.80% SMA501.47% SMA2004.14% Volume80 Change0.05%
Jan-04-18 11:50AM  What Is The Future Prospect For Financials And KBL Merger Corp IV (NASDAQ:KBLM)? Simply Wall St.
KBL Merger Corp. IV is a private equity firm specializing in acquisition, buyout, PIPES and secondaries investments. The firm seeks to invest in healthcare or the healthcare-related wellness industry. In healthcare services the firm seeks to invest in outpatient care, physician practices, behavioral health and payor services. In pharma services the firm seeks to invest in outsourced services, contract research and generics / OTC. In health IT the firm seeks to invest in EMR / HER, revnue cycle management, telemedicine and care management. In minimal reimbursement risk the firm focuses on retail healthcare, wellness and preventative care. In devices and diagnostics the firm focuses on medical devices, diagnostics, genetic testing and lab tools. The firm typically invests in firms located in the United States. The firm seeks to invest in firms with valuation between $200 million to $700 million and EBITDA between $20 million to $70 million. The firms invest in firms with enterprise value $200 million to $700 million. The firm seeks to take majority stakes. KBL Merger Corp. IV was founded in 2016 and is New York, New York with an additional office in Newark, Delaware.